• Molecular NameBifonazole
  • Synonym(+-)-1-(p,alpha-Diphenylbenzyl)imidazole; (+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; 1-(p,alpha-Diphenylbenzyl)imidazole; Bay h 4502; Bifonazol [inn-spanish]; Bifonazolum [inn-latin]; Trifonazole
  • Weight310.4
  • Drugbank_IDDB04794
  • ACS_NO60628-96-8
  • Show 2D model
  • LogP (experiment)4.77
  • LogP (predicted, AB/LogP v2.0)5.18
  • pkaN/A
  • LogD (pH=7, predicted)4.71
  • Solubility (experiment)0.000348 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-4.08
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors0
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds4
  • TPSA17.82
  • StatusFDA approved
  • Administrationtopic
  • PharmacologyAn imidazole antifungal drug.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A